Potassium orotate, tablets 500 mg 30 pcs

As part of the combined therapy:

• liver and biliary tract diseases caused by intoxication (except cirrhosis with ascites);
• myocardial infarction and chronic heart failure stages II and III;
• cardiac rhythm disorders (especially extrasystole and atrial fibrillation;
• dermatoses;
• alimentary and alimentary-infectious hypotrophy in children, progressive muscular dystrophy.

Reconvalescence period, increased physical activity.

Indications

As part of combination therapy:

diseases of the liver and biliary tract caused by intoxications (except for cirrhosis with ascites);
myocardial infarction and chronic heart failure stages II and III;
heart rhythm disturbances (especially with extrasystole and atrial fibrillation);
dermatoses;
nutritional and nutritional-infectious malnutrition in children, progressive muscular dystrophy.

Convalescence period, increased physical activity.

Pharmacological effect

Non-hormonal anabolic agent.

Active ingredient

Orotic acid

Composition

1 table potassium orotate 0.5 g

Contraindications

Liver cirrhosis with ascites,
nephrourolithiasis,
chronic renal failure,
hypersensitivity to orotic acid.

Recommendations for use

Take 250-500 mg orally 2-3 times a day 1 hour before meals or 4 hours after meals.

Storage conditions

In a dry place, at a temperature not exceeding 25 °C.

Manufacturer

Irbitsky Chemical Plant, Russia